AIkido Pharma (NASDAQ:AIKI) Stock Passes Above 200-Day Moving Average – Here’s What Happened

AIkido Pharma Inc. (NASDAQ:AIKIGet Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.79 and traded as high as $6.25. AIkido Pharma shares last traded at $5.55, with a volume of 233,412 shares changing hands.

AIkido Pharma Stock Performance

The company has a market cap of $30.44 million, a PE ratio of -1.43 and a beta of 0.93. The stock’s 50-day simple moving average is $4.76 and its 200 day simple moving average is $2.79.

About AIkido Pharma

(Get Free Report)

AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.

Featured Stories

Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.